BACKGROUND: Considerable hospital-to-hospital variations in surgical outcomes have been reported across surgical procedures. However, it is unclear whether hospital quality rankings are consistent for noncancer and cancer operations. We investigated the differences in hospital performance for noncancer and cancer colorectal resections at 52 hospitals participating in the Michigan Surgical Quality Collaborative (MSQC). STUDY DESIGN: Patients undergoing colorectal resections between 2008 and 2012 were identified. Hierarchical risk-adjusted models were used to evaluate hospital level 30-day morbidity, major morbidity, extended length-of-stay (LOS > 75 th percentile), and mortality outcomes. Hospital performance, as ranked by observed-to-expected ratios, was compared by rank-order changes, interquartile ranges (IQR), and Spearman's correlations.
Of the 19,990 colorectal resections, 7,292 (36.5%) were for cancer. We observed wide variations in all risk-adjusted 30-day outcomes between hospitals, but only weak correlations in cancer and noncancer performance within hospitals. Overall hospital performance in mortality after noncancer and cancer operations was not correlated (Spearman's rho: 0.02). Of the best performing hospitals in mortality after noncancer resections, 69% were reclassified to a worse quartile for cancer operations (median rank-change of 12.5 ranks [IQR 5 to 27]). Similarly, hospital performance in morbidity was only moderately correlated (rho: 0.59; p < 0.001). Of the hospitals with lowest morbidity rates for noncancer resections, 31% were reclassified. We noted a similar lack of relationship in major morbidity and extended LOS. CONCLUSIONS: A hospital's performance ranking in risk-adjusted outcomes after noncancer colorectal resections does not correlate to its performance for cancer-related colorectal resections. Indication for operation should be considered when leveraging risk-adjusted hospital outcomes for quality improvement efforts. Multiple reports have consistently demonstrated wide variation in outcomes after surgical procedures across hospitals, and measuring quality using risk-adjusted outcomes has become a widespread practice. However, the vast majority of these data are reported at the procedural level and do not uniquely distinguish between differing indications for the procedures themselves. [1] [2] [3] [4] [5] This makes it difficult to fully understand outcomes after colorectal resections, which are commonly performed operations at all types of hospitals and are done for a wide range of indications. Although colorectal procedures are thought of as technically similar, noncancer and cancer patients represent distinct populations with varying risk factors and different perioperative circumstances. As yet, there are no robust mechanisms in place to specifically assess the quality of cancer surgery care at hospitals. Current quality reports are based on the assumption that hospital performance rankings are consistent among all indications for similar procedures. 6, 7 So current colorectal surgery benchmarks may not truly represent reality. Further, grouping patients with and without cancer into the same quality profiling models may obfuscate valuable information regarding best practices for noncancer and cancer resections and respective targets for improvement.
To our knowledge, there have not been any published studies comparing hospital performance rankings for noncancer and cancer indications across similar procedures. In this context, we investigated the differences in hospital performance when different indications were examined using risk-and reliability-adjusted short-term outcomes after colorectal resections at 52 hospitals participating in a regional collaborative in the state of Michigan.
METHODS

Data sources
The Michigan Surgical Quality Collaborative (MSQC) is a 52-hospital consortium representing diverse practice settings throughout the state. Abstraction of MSQC data and data quality assurance details have been described elsewhere. 8, 9 In brief, specially trained data abstractors conduct chart reviews to comprehensively collect patient demographics, preoperative risk factors, laboratory values, technical details of the operations, perioperative processes of care, and 30-day outcomes for patients undergoing specified surgical operations, using a sampling algorithm that minimizes selection bias. Regular data audits ensure registry data validity. Data collection for MSQC is Institutional Review Board (IRB) exempt at participating hospitals, and this study was deemed nonregulated by the University of Michigan's IRB.
Patient population
Patients aged 18 years and older, who had undergone a colorectal resection based on index Current Procedural Terminology (CPT) codes at any of the 52 participating hospitals, were identified from the MSQC dataset from 2008 to 2012 (CPT codes 44139e44160, 44204e44213, 45110e45135, and 45395e45550). International Classification of Disease (ICD-9) codes were analyzed and patients were categorized to the cancer group if their ICD-9 codes represented any invasive or metastatic malignancy (ICD-9 codes 140e209.3), the remaining ICD-9 codes in the noncancer category encompassed 8 different indications, namely, diverticulitis, benign neoplasms, vascular insufficiency, obstruction/ volvulus, inflammatory bowel disease (IBD), hemorrhage, stoma complications, and other diagnoses. Polyps with or without carcinoma in situ and benign neuroendocrine tumors were classified as benign neoplasms.
Independent variables
Clinical and demographic data analyzed included age, race, sex, American Society of Anesthesiologists (ASA) class, functional status, body mass index (BMI), indication for operation (from postoperative diagnosis ICD-9 codes), type of operation (from CPT codes), complexity of the operation and concurrent procedures, and emergent status. Comorbidities included preoperative cardiac, pulmonary, gastrointestinal, renal, neurologic, hematologic, infectious, and endocrine diagnoses. Patients may have had disseminated cancer unrelated to their colorectal resection hospitalization and were classified in the noncancer operation cohort.
Outcomes variables
The primary outcomes of interest were any morbidity, major morbidity, extended length of stay (LOS), and mortality within 30 days of the index operation, in patients who had colorectal resections for noncancer and cancer indications. Morbidity was defined as having documentation of at least 1 postoperative complication, including superficial surgical site infection (SSI), deep space SSI, organ space SSI, wound dehiscence, pneumonia, unplanned intubation, pulmonary embolism, ventilator dependence greater than 48 hours, acute kidney injury, urinary tract infection, neurologic event, cardiac arrest, myocardial infarction, bleeding requiring transfusion, venous thromboembolism (deep vein thrombosis or pulmonary embolism), sepsis, severe sepsis, central line associated blood stream infection, Clostridium difficile infection, and anastomotic leak. Major morbidity was defined as above, with the exclusion of deep vein thrombosis without evidence of pulmonary embolism, superficial SSI, deep space SSI, UTI, and C. difficile infection. Patients could experience more than 1 of the listed complications. Conditions present preoperatively were not included as a complication because this study focused on postoperative outcomes. Extended LOS was defined as extending beyond the 75 th percentile for LOS in this cohort. Readmission data were not available for this patient population.
Statistical analyses
Clinical and demographic variables for patients who underwent noncancer and cancer colorectal resections were compared using chi-square tests for categorical and In total, 4 models were constructed, with significance set at p < 0.05. Models were evaluated for discrimination using the c-statistic and for goodness-of-fit using Hosmer-Lemeshow statistics. The c-statistic evaluates model discrimination and represents the area under the receiver operator characteristic curve. A value of 0.5 indicates that the model is equivalent to chance; a value of 1.0 indicates perfect discrimination. In other words, the c-statistic is the probability that a random patient who experienced the outcome will have a higher risk score than a random patient who did not. The Hosmer-Lemeshow statistic assesses whether predictive accuracy is consistent across deciles of predicted risk. These models yielded patient-level predicted probabilities and risk scores for each outcome across all hospitals.
To account for clustering and random variation in hospital outcomes rates, hierarchical regression modeling and empirical Bayesian methods were used to ensure statistical reliability. The reliability adjustment minimizes variation due to sample size at the hospital level. Surgeon level data were not available for this analysis. Predicted probabilities were summed at the hospital level to estimate risk-and reliability-adjusted rates for each outcome of interest for cancer and noncancer operations. For each hospital, the observed number of events (O) was divided by the riskadjusted expected number of events (E) to produce observed-to-expected (O/E) ratios. If the 95% confidence interval of the O/E ratio did not include 1.0, then the hospital was designated as a statistically significant "outlier." In total, 8 O/E ratios were calculated per hospital (1 per outcome in each group).
To compare performance based on indication for resection, hospital level statistics were evaluated for each noncancer and cancer designation. For each outcome of interest, hospitals were ranked based on their O/E ratios and divided into even quartiles of performance rankings. Spearman correlation statistics were used to compare hospital ranks in outcomes after noncancer and cancer resections, with a Spearman's correlation coefficient (rho), which ranges from zero (no association) to 1 (perfect association). Differences in performance for noncancer and cancer operations were quantified by changes in hospital rank. Absolute values for changes in hospital rank and their interquartile ranges (IQR) were calculated for each outcome of interest. All statistical analyses were conducted using STATA special edition (version 13, StataCorp).
RESULTS
Baseline characteristics and case mix
In total, 19,990 colorectal resections were performed at 52 MSQC hospitals. The most commonly performed operations were open partial colectomies, followed by laparoscopic partial colectomies. Of those, 7,364 (36.8%) were cancer-directed operations. Patient-level clinical and demographic characteristics are summarized in Table 1 . Overall, patients undergoing noncancer operations had poorer functional status (partially or totally dependent functional status), higher rates of comorbid conditions (congestive heart failure, current use of cigarettes, COPD, pneumonia or ventilator dependence, renal failure/dialysis), higher ASA scores, a higher association with preoperative sepsis, and had more cases designated as emergencies. Of the 12,626 noncancer operations, diverticulitis was the most common indication, accounting for more than half of the cases. Operations for inflammatory bowel disease represented a relatively small proportion (5.9%) of the noncancer operations. Table 2 depicts the risk factors that were accounted for in each predictive model. Our statistical models compared favorably to other published risk-adjusted models, with all models having a c-statistic >0.7.
10,11
At the hospital level, wide inter-and intrahospital variations in performance rankings were identified across all outcomes of interest after noncancer and cancer resections. This is demonstrated by the dramatic changes in rank relative to other hospitals and the poor correlation coefficients when comparing both indications, as summarized below.
Morbidity Differences in hospital performance rankings for morbidity were evident when examining noncancer vs cancer operations. Adjusted morbidity rates varied widely between hospitals, with a mean of 29.9% (range by hospital 17.6% to 45.3%) for noncancer, compared with 25.3% (range by hospital 18.2% to 30.4%) for cancer resections (p < 0.001). Although in aggregate, morbidity rates seem to be lower in the cancer group, this was not consistent at all hospitals, which significantly affected rankings relative to other hospitals. In total, 8 high performing outliers were identified (Fig. 1A) , but only 1 of those sites performed consistently well for both noncancer and cancer indications based on O/E ratios. Hospitals had a median rank change of 6 ranks (IQR 2 to 14) and only weak-to-moderate ranking 
correlations between indications (Spearman's rho: 0.59, p < 0.001). Furthermore, 31% of hospitals in the top performance quartile for morbidity after noncancer resections were reclassified to a lower performance quartile for cancer resections ( Fig. 2A) .
Major morbidity
Similarly, risk-adjusted major morbidity rates were 22.3% (range 14.1% to 34.6%) for noncancer vs 18.8% (range 13.8% to 22.7%) for cancer. None of the 4 high performing outliers shown in Figure 1B were consistent as high performing for both indications. As demonstrated in Figure 2B , hospital ranks were weakly correlated (rho: 0.39, p < 0.001). There was an overall median rank change of 11 (IQR 5 to 16). From the top rankings quartile for noncancer operations, 62% of hospitals were reclassified to a lower rankings quartile when cancer resections were examined. (Fig. 1C) . Sixty-two percent of hospitals in the top rankings quartile were reclassified (Fig. 2C ). There was a median rank change of 11.5 (IQR 4 to 19) and only weak rank correlations (rho: 0.39, p ¼ 0.004).
Mortality
The most dramatic differences were noted in hospital performance rankings for mortality after noncancer compared with cancer operations. Adjusted mortality rates were 6.1% (range 5% to 7.6%) vs 3.4% (range 2.7% to 4.6%), respectively. Even though all hospitals had lower risk-adjusted mortality rates after cancer surgery, their respective performance rankings were not correlated (rho: 0.02, p > 0.2) across the 2 indications. There was a median change of 12.5 hospital ranks (IQR 5 to 27) based on indication for operation. Lastly, 69% of the top ranking hospitals in mortality dropped to a lower performance quartile (Figs. 1D and 2D ) when evaluating performance based on noncancer operations to cancer operations.
Post-hoc analyses
Overall, patients undergoing noncancer operations appeared to be a higher risk cohort based on clinical characteristics. The differences in outcomes were attenuated after risk adjustment, but remained significant. To further test the robustness of these results, we explored the possibility that higher risk patients did not undergo elective operations, and more generalized patient selection influenced hospital performance in morbidity and mortality. Sensitivity analyses excluded patients undergoing emergent operations and those with an ASA class of 4 or higher. Only minimal changes in O/E ratios for the outcomes of interest were noted and did not influence rank correlations. Another post-hoc analysis took into account the fact that benign polyps receive oncologic resections similar to those of the cancer cohort, the results were similar to the main analysis and are not reported. Similarly the effect of the formation of a new stoma on extended LOS was examined, minimal changes in riskadjusted rates resulted without affecting ranking differences.
DISCUSSION
In our study of nearly 20,000 colorectal resections at 52 hospitals across the state of Michigan, we found wide variation in hospital-level risk-and reliability-adjusted short-term outcomes across indications. Based on O/E ratios and hospital rankings, the overwhelming majority of hospitals do not perform consistently for noncancer vs cancer colorectal resections in any of the outcomes measures we examined, particularly mortality and major morbidity. Almost no hospitals were consistently high performers for both noncancer and cancer operations. Hospitals are increasingly being benchmarked against other hospitals based on risk-adjusted, postoperative short-term outcomes as an indicator of surgical quality.
12,13 Short-term outcomes are also on the agenda of national health policy, public reporting, and pay-forperformance initiatives. In this context, colorectal surgery has gained considerable attention because it accounts for approximately 10% of all general surgery operations in the US and contributes to the greatest share of adverse events.
14 Similar to previous studies, this work shows significant variations in outcomes after colorectal surgery. However, to the best of our knowledge, our study is the first to directly compare hospital performance in noncancer surgery with that in cancer surgery, uncovering significant differences in hospital performance related to indication alone.
Most studies evaluate colorectal surgery outcomes for all patients regardless of cancer status. 1, 15, 16 For example, in their assessment of 182 NSQIP hospitals, Cohen and colleagues 1 demonstrated sizable hospital variations in LOS after colorectal surgery. Our study demonstrates substantial differences in LOS performance similar to the NSQIP study, but adds a crucial aspect in directing quality interventions toward potential targets of improvement in process or structure, which would not otherwise be identifiable if patients were grouped together irrespective of indication. In our study, the majority of the hospitals were not consistent in their extended LOS performance. This may signify that cancer patients may be staying longer at a particular hospital compared with their noncancer counterparts, which might be due to a lack of timely coordination of multidisciplinary care or discharge location, while noncancer patients, who do not require further therapy, return home in a timely fashion. In another NSQIP analysis, Ingraham and associates 16 found differences in hospital performance between emergent and nonemergent colorectal operations. The results in this study persisted after excluding high-risk and emergent cases in the post-hoc analysis.
Other studies have specifically analyzed outcomes after colorectal resections for cancer alone. 7, 17, 18 In their SEER-Medicare study on 4,617 patients with stage I to III colon cancer at 465 hospitals, Zheng and coworkers 18 found significant interhospital variations in LOS and mortality rates that were attributed to the hospital center effect. The hospital center effect was used to describe variation in health outcomes that is directly attributable to the hospital at which treatment occurs, after controlling for patient-, provider-, and hospital-level characteristics. Their findings suggested that the choice of hospital affects outcomes independently of other confounding variables. In this study, the overwhelming majority of hospitals did not perform consistently across indications. Therefore, current hospital rankings based on procedural analyses tell only part of the story.
In a patient-level analysis using the Nationwide Inpatient Sample, Van Arendonk and colleagues 19 highlighted the limitations of not comparing patient outcomes across disease types; the outcomes of colectomy varied dramatically according to the underlying diagnosis requiring surgery. Our study confirms these differences at the hospital level and demonstrates that hospitals do not perform consistently when similar procedures for differing indications are compared. The contrasting hospital performance within different disease settings emphasizes the limitations of comparing health care quality based on patients' surgical outcomes alone, without addressing the specific disease process requiring surgery.
It will be important to determine the effect of distinguishing high or low performance rankings based on indication for the procedure to uncover the important hospital-level processes of care for distinct diseases. One explanation for disparate results may be that different surgeons at the same hospitals perform cancer resections as opposed to resections for diverticulitis. Specifically, elective cancer operations are more likely to be performed by surgical specialists (surgical oncologists or colorectal surgeons) than more urgent operations for diverticulitis, which present as "on call" cases and are not always triaged to specialists. Further, different systems of care may be in place at the same hospital for inflammatory bowel disease compared with rectal cancer even though both are examples of cases likely to be managed by colorectal surgeons, and this could account for differences in perioperative outcomes. Although this is not a classic example of "confounding by indication," which describes biased estimates of treatment effects, colorectal operations are common and the results from this study do illustrate the importance of precise measurement to avoid bias. Procedure-specific quality reports are insufficient to accurately profile hospital performance.
The American College of Surgeons has recognized the need to report hospital performance for cancer cases separately. For this purpose, it has developed the Oncology NSQIP National Cancer Institute Center Consortium (ONNCC). As a cancer-specific quality Abdelsattar et al Noncancer vs Cancer Surgery Performanceplatform, ONNCC can accurately benchmark hospital performance for cancer cases. 6 Similarly, the MSQC has begun to separately report cancer surgery outcomes to hospitals in order to better understand cancer surgery care and the unique potential targets for improvement. Echoing this, our study is the first to confirm the need for a robust cancer platform such as ONNCC, by comparing hospital-ranking differences after noncancer and cancer resections.
Our study is not without limitations. First, because this study was limited to colorectal resections, results may not be generalizable to other types of operations. However, other gastrointestinal operations such as esophagectomy, gastrectomy (excluding bariatric procedures), hepatectomy, or pancreatectomy are overwhelmingly performed for cancers or other neoplasms and do not lend themselves to the same type of comparison. Because surgeonspecific data are not included in this analysis, we are unable to define if varying practice patterns, which may be seen when comparing colorectal surgeons to acute care surgeons, can explain the differences in hospital rankings for noncancer vs cancer resections, even if they are performed at the same hospital. Even though our methods adjusted for clustering effects within hospitals, the extent to which surgeon-specific practices for noncancer care compared with cancer care could not be directly assessed.
CONCLUSIONS
Our results demonstrated substantial intrahospital variation in risk-and reliability-adjusted outcomes for cancer and noncancer colorectal resections. For major morbidity and mortality measures, almost no hospitals were consistently high performers for both indications. In an era of transparency and public reporting of hospital performance, these findings show that indication-specific reporting and targeted improvement strategies may be particularly important for improving outcomes after colorectal operations. 
